A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Summary

The purpose of this study is to evaluate the safety and the immunogenicity of two different doses of the GVGH S. sonnei vaccine in healthy adults and represents the first step towards testing of the GMMA vaccine in the vaccine target population of children from developing countries where shigellosis is endemic.

Timeline

Start

2016-08-08

Primary completion

2017-03-10

Completion

2017-03-10

Drugs

Indications